Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation - a case report.
Case report
Dyspnea
Invasive cardiopulmonary exercise testing
Lactate
Metabolic myopathy
Mitochondriopathy
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
29 Mar 2023
29 Mar 2023
Historique:
received:
29
12
2022
accepted:
16
03
2023
medline:
31
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Primary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findings that can be classified in the known pathologies of mitochondrial deletion syndrome. The patient presented to us at 29 years of age, having had tachycardia, dyspnea, and functional impairment since childhood. She had been diagnosed with bronchial asthma and mild left ventricular hypertrophy and treated accordingly, but her symptoms had worsened. After more than 20 years of progressive physical and social limitations was a mitochondrial disease suspected in the exercise testing. We performed cardiopulmonary exercise testing (CPET) with right heart catheterization showed typical signs of mitochondrial myopathy. Genetic testing confirmed the presence of a ~ 13 kb deletion in mitochondrial DNA from the muscle. The patient was treated with dietary supplements for 1 year. In the course of time, the patient gave birth to a healthy child, which is developing normally. CPET and lung function data over 5 years demonstrated stable disease. We conclude that CPET and lung function analysis should be used consistently to evaluate the cause of dyspnea and for long-term observation.
Sections du résumé
BACKGROUND
BACKGROUND
Primary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findings that can be classified in the known pathologies of mitochondrial deletion syndrome.
CASE PRESENTATION
METHODS
The patient presented to us at 29 years of age, having had tachycardia, dyspnea, and functional impairment since childhood. She had been diagnosed with bronchial asthma and mild left ventricular hypertrophy and treated accordingly, but her symptoms had worsened. After more than 20 years of progressive physical and social limitations was a mitochondrial disease suspected in the exercise testing. We performed cardiopulmonary exercise testing (CPET) with right heart catheterization showed typical signs of mitochondrial myopathy. Genetic testing confirmed the presence of a ~ 13 kb deletion in mitochondrial DNA from the muscle. The patient was treated with dietary supplements for 1 year. In the course of time, the patient gave birth to a healthy child, which is developing normally.
CONCLUSION
CONCLUSIONS
CPET and lung function data over 5 years demonstrated stable disease. We conclude that CPET and lung function analysis should be used consistently to evaluate the cause of dyspnea and for long-term observation.
Identifiants
pubmed: 36991405
doi: 10.1186/s12890-023-02391-x
pii: 10.1186/s12890-023-02391-x
pmc: PMC10061947
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104Informations de copyright
© 2023. The Author(s).
Références
Curr Neurol Neurosci Rep. 2010 Mar;10(2):118-26
pubmed: 20425236
Brain. 2003 Feb;126(Pt 2):413-23
pubmed: 12538407
Circulation. 2010 Jul 13;122(2):191-225
pubmed: 20585013
J Neurol. 2016 Jan;263(1):179-91
pubmed: 26315846
Lancet. 2004 Aug 14-20;364(9434):592-6
pubmed: 15313359
Curr Opin Neurol. 2019 Oct;32(5):715-721
pubmed: 31408013
Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S129-S139
pubmed: 28590155
J Child Neurol. 2014 Sep;29(9):1225-34
pubmed: 25008908
J Biomed Biotechnol. 2010;2010:340849
pubmed: 20589068
Essays Biochem. 2018 Jul 20;62(3):467-481
pubmed: 29980632
Am J Respir Crit Care Med. 2002 Jul 1;166(1):118-9; author reply 119-20
pubmed: 12118470
Mitochondrion. 2019 May;46:214-220
pubmed: 29990538
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52
pubmed: 22336677
Eur Respir J. 1988 May;1(5):445-52
pubmed: 3139446
Am J Respir Crit Care Med. 2001 Aug 1;164(3):425-32
pubmed: 11500344